Robotic Surgery Recommended For Obese Patients

Robotic Surgery Recommended For Obese Patients

Researchers examined records of 9,108 obese men who underwent radical prostatectomy (removal of the prostate gland and some surrounding tissue). Among all patients, 60.4 percent underwent robotic-assisted radical prostatectomy and 39.6 percent underwent open prostatectomy.

Read More

New Treatment for Recurrent Prostate Cancer

New Treatment for Recurrent Prostate Cancer

The potential foundation for a next-generation therapy, called tetraaryl cyclobutane, or CB, is being studied as an option for prostate tumors that have grown resistant to current anti-androgen drugs, notably enzalutamide.

Read More

Is There an Antibody for Prostate Cancer?

Is There an Antibody for Prostate Cancer?

In the study published in the journal Oncotarget, 10 men with metastatic prostate cancer resistant to androgen deprivation therapy and the androgen receptor antagonist enzalutamide were treated with pembrolizumab, a monoclonal antibody that binds to the PD-1 receptor.

Read More

Fight prostate cancer with diet changes

Fight prostate cancer with diet changes

Diet appears to play a role in the development of prostate cancer.  Many studies have revealed that consuming a healthy diet has a strong influence on whether a man may develop this disease or not. 

Read More